ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,903Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 2094

$800K Total Retail Price of All Prescriptions

Rank: 176 out of 2094

480 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 9,643 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 424 361 1 4
WARFARIN SODIUM 362 318 2 11
AMLODIPINE BESYLATE 343 329 3 2
FUROSEMIDE 333 288 4 6
SIMVASTATIN 289 273 5 1
LEVOTHYROXINE SODIUM 266 244 6 3
POTASSIUM CHLORIDE 228 205 7 24
METOPROLOL TARTRATE 227 199 8 10
GABAPENTIN 183 118 9 23
METOPROLOL SUCCINATE 177 164 10 9
OXYCODONE-ACETAMINOPHEN 144 120 S2 11 40
TRAMADOL HCL 143 131 12 33
METFORMIN HCL 136 123 13 8
MIRTAZAPINE 134 134 14 43
LISINOPRIL 131 127 15 7
FLUTICASONE PROPIONATE 128 90 16 41
JANUVIA 123 123 17 35
SERTRALINE HCL 122 94 18 26
ATORVASTATIN CALCIUM 117 108 19 5
DONEPEZIL HCL 116 116 20 20
FAMOTIDINE 101 94 21 34
ENALAPRIL MALEATE 101 99 21 25
NEXIUM 96 88 23 16
CLONIDINE 95 86 24 261
AZITHROMYCIN 92 73 25 27
QUETIAPINE FUMARATE 91 84 26 71
LEVOCETIRIZINE DIHYDROCHLORIDE 89 79 27 169
CYMBALTA 89 66 27 61
LOSARTAN POTASSIUM 82 81 29 17
CARVEDILOL 81 78 30 19
CITALOPRAM HBR 80 68 31 47
CLOPIDOGREL 79 66 32 22
ATENOLOL 79 63 32 21
PREDNISONE 79 72 32 54
LIDODERM 78 75 35 59
METOLAZONE 77 60 36 216
PAROXETINE HCL 75 75 37 77
ADVAIR DISKUS 75 61 37 36
HYDROCHLOROTHIAZIDE 72 72 39 12
HYDROCODONE-ACETAMINOPHEN 70 46 S3 40 42
RAMIPRIL 69 62 41 48
DIGOXIN 67 67 42 51
CARBIDOPA-LEVODOPA 67 67 42 102
TRAZODONE HCL 66 65 44 72
FENTANYL 65 65 S2 45 68
TAMSULOSIN HCL 64 64 46 29
DIOVAN 62 58 47 13
SANTYL 61 56 48 114
AMLODIPINE BESYLATE-BENAZEPRIL 60 52 49 58
PLAVIX 58 45 50 38
ESCITALOPRAM OXALATE 58 57 50 46
NOVOLOG 57 57 52 116
AMIODARONE HCL 52 51 53 175
CLONIDINE HCL 51 45 54 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.